Andrew Liu

444 total citations
14 papers, 332 citations indexed

About

Andrew Liu is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Andrew Liu has authored 14 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in Andrew Liu's work include Immunodeficiency and Autoimmune Disorders (4 papers), Diabetes and associated disorders (3 papers) and Hepatitis B Virus Studies (3 papers). Andrew Liu is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (4 papers), Diabetes and associated disorders (3 papers) and Hepatitis B Virus Studies (3 papers). Andrew Liu collaborates with scholars based in United States, China and Iraq. Andrew Liu's co-authors include Yuchen Xia, Kaitao Zhao, Daniel N. Streblow, Victor R. DeFilippis, Jinu Abraham, Aaron Nilsen, Tina M. Sali, Kara Pryke, Jessica L. Smith and Ahmed Majeed Al-Shammari and has published in prestigious journals such as PEDIATRICS, PLoS Pathogens and mBio.

In The Last Decade

Andrew Liu

13 papers receiving 318 citations

Peers

Countries citing papers authored by Andrew Liu

Since Specialization

Citations

This map shows the geographic impact of Andrew Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Liu more than expected).

Fields of papers citing papers by Andrew Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Liu. The network helps show where Andrew Liu may publish in the future.

Co-authorship network of co-authors of Andrew Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Liu. A scholar is included among the top collaborators of Andrew Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Liu. Andrew Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Prehospital Naloxone Administration Patterns during the Era of Synthetic Opioids 2023 ·Prehospital Emergency Care ·Andrew Liu, (unknown), Matthew D. Shapiro, Jeffrey M. Boyd, (unknown), (unknown), David C. Cone, (unknown)	5
2	Belimumab use during pregnancy: Interim results of the belimumab pregnancy registry 2022 ·Birth Defects Research ·Patricia Juliao, Keele Wurst, Jeanne M. Pimenta, (unknown), Helain J. Landy, M. Anthony Moody, Hugh H. Tilson, Deborah L. Covington, (unknown), (unknown), Jennifer Gilbride, Andrew Liu, (unknown), Michelle Petri	18
3	Insights into Hepatitis B Virus DNA Integration-55 Years after Virus Discovery 2020 ·The Innovation ·Kaitao Zhao, Andrew Liu, Yuchen Xia	51
4	Clinical characteristics of COVID‐19 patients with hepatitis B virus infection — a retrospective study 2020 ·Liver International ·Rui Liu, Li Zhao, Xiaoming Cheng, Huan Han, Cong Li, Li Dong, Andrew Liu, Guosheng Gao, Feng Zhou, Fang Liu, Yingan Jiang, Chengliang Zhu, Yuchen Xia	46
5	Proton Therapy for Locally Advanced Oropharyngeal Cancer: Initial Clinical Experience at the University of Washington 2019 ·International Journal of Particle Therapy ·(unknown), Andrew Liu, Tony Wong, Jay J. Liao, George E. Laramore, Upendra Parvathaneni	20
6	A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses 2017 ·mBio ·Kara Pryke, Jinu Abraham, Tina M. Sali, (unknown), (unknown), Andrew Liu, Shelly Bambina, Jason R. Baird, Michael J. Gough, (unknown), Elias K. Haddad, Ilsa T. Kirby, Aaron Nilsen, Daniel N. Streblow, Alec J. Hirsch, Jessica L. Smith, Victor R. DeFilippis	31
7	Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses 2015 ·PLoS Pathogens ·Tina M. Sali, Kara Pryke, Jinu Abraham, Andrew Liu, (unknown), Rebecca M. Broeckel, Julia A. Staverosky, Jessica L. Smith, Ahmed Majeed Al-Shammari, (unknown), (unknown), Aaron Nilsen, Daniel N. Streblow, Victor R. DeFilippis	95
8	The Association of Opportunistic Infections with the Occurrence of Trimethoprim/Sulfamethoxazole Hypersensitivity in Patients Infected with Human Immunodeficiency Virus 1999 ·The Journal of Clinical Pharmacology ·David F. Lehmann, Andrew Liu, Nancy Newman, Donald C. Blair	14
9	HIGH LEVELS OF HIV-1 IN PLASMA DURING ALL STAGES OF INFECTION DETERMINED BY COMPETITIVE PCR 1995 ·PEDIATRICS ·Catherine Van Kerckhove, Andrew Liu	1
10	ALLERGEN IMMUNOTHERAPY DECREASES INTERLEUKIN-4 PRODUCTION IN CD4+ T CELLS FROM ALLERGIC INDIVIDUALS 1995 ·PEDIATRICS ·(unknown), Andrew Liu	0
11	THE CD40 LIGAND gp39, IS DEFECTIVE IN ACTIVATED T CELLS FROM PATIENTS WITH X-LINKED HYPER-IgM SYNDROME 1994 ·PEDIATRICS ·(unknown), Andrew Liu	13
12	CD40 LIGAND GENE DEFECTS RESPONSIBLE FOR X-LINKED HYPER-IgM SYNDROME 1994 ·PEDIATRICS ·(unknown), Andrew Liu	12
13	DEFECTIVE EXPRESSION OF T-CELL CD40 LIGAND CAUSES X-LINKED IMMUNODEFICIENCY WITH HYPER IgM 1994 ·PEDIATRICS ·(unknown), Andrew Liu	12
14	DEFICIENT EXPRESSION OF A B CELL CYTOPLASMIC TYROSINE KINASE IN HUMAN X-LINKED AGAMMAGLOBULINEMIA 1994 ·PEDIATRICS ·(unknown), Andrew Liu	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact